Avalon announced that it received a notice from Nasdaq stating that the company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250 because the company has not yet filed its quarterly report on Form 10-Q for the fiscal quarter ended March 31 with the SEC.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALBT:
- Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
- Avalon announces launch of U.S. sales of KetoAir Breathalyzer
- Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union
- Avalon GloboCare extends exclusivity agreement to distribute KetoAir